Insider · CIK 0001413822
Anastasios Gianakakos
Files at LIANY (LianBio), KARD (Kardigan, Inc.). First filing -, latest -.
In brief
Anastasios Gianakakos files SEC Form 4 as CEO, president and director at LIANY (LianBio), and also at KARD (Kardigan, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Anastasios Gianakakos has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Common Stockindirect: By AEG 2021 Trust | +28,702 | - | - | 5,665,090 | Jun 22, 2026 |
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Common Stockindirect: By KCM 2023 Trust | +41,001 | - | - | 2,422,520 | Jun 22, 2026 |
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Common Stockindirect: By spouse | +498,692 | - | - | 498,692 | Jun 22, 2026 |
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Series A Preferred Stockderivativeindirect: By AEG 2021 Trust | -18,020 | - | - | 0 | Jun 22, 2026 |
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Series A Preferred Stockderivativeindirect: By KCM 2023 Trust | -25,742 | - | - | 0 | Jun 22, 2026 |
| Jun 17, 2026 | KARD Kardigan, Inc. | CConversion Series B Preferred Stockderivativeindirect: By spouse | -313,092 | - | - | 0 | Jun 22, 2026 |
| Feb 15, 2024 | LIANY LianBio | MOption exercise Ordinary Shares | +36,300 | $2.52 | $91k | 72,848 | Feb 20, 2024 |
| Feb 15, 2024 | LIANY LianBio | FTax withholding Ordinary Shares | -19,218 | $4.76 | $91k | 53,630 | Feb 20, 2024 |
| Feb 15, 2024 | LIANY LianBio | MOption exercise Stock Option (Right to Buy)derivative | -36,300 | $0.00 | $0 | 0 | Feb 20, 2024 |
| Jun 21, 2023 | LIANY LianBio | AGrant or award Stock Option (Right to Buy)derivative | +36,300 | $0.00 | $0 | 36,300 | Jun 23, 2023 |
Questions about Anastasios Gianakakos
Answered from the filings on this page, as of the latest one.
Is Anastasios Gianakakos buying or selling?
Anastasios Gianakakos has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Anastasios Gianakakos's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anastasios Gianakakos has 0.
Where does Anastasios Gianakakos file Form 4?
Anastasios Gianakakos has filed Form 4 at LIANY (LianBio); KARD (Kardigan, Inc.) as President & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.